α-Helical CRF9-41 prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats

NeuroReport

Volumn 8, Issue 16, 1997, Pages 3645-3647

  Kask, Ants ^a   Rägo, Lembit ^a   Harro, Jaanus ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Anxiety; Corticotropin releasing factor; Elevated plus maze; Neuropeptide Y Y1 receptor; Neuropeptide Y Y1 receptor antagonist; Rat

Indexed keywords

CORTICOTROPIN RELEASING FACTOR[9-41]; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANXIETY; ANXIETY NEUROSIS; ARTICLE; DRINKING; DRUG EFFECT; EMOTION; FEEDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEXUAL BEHAVIOR;

EID: 0030664322     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199711100-00044     Document Type: Article

References (20)

1. Chronwall BM, DiMaggio DA, Massari VJ et al. Neuroscience 15, 1159-1181 (1985).
2. Wahlestedt C and Reis DJ, Annu Rev Pharmacol Toxicol 32, 309-352 (1993).
3. Larhammar D. Reg Peptides 65, 165-174 (1996).
4. Kask A, Rägo L and Harro J. Eur J Pharmacol 317, R3-R4 (1996).
5. Dunn AJ and Berridge CW. Brain Res Rev 15, 71-100 (1990).
6. Heinrichs SC, Menzaghi F, Pich EM et al. Neuropsychopharmacology 11, 179-186 (1994).
7. Heilig M, Koob GF, Ekman R et al. Trends Neurosci 17, 80-85 (1994).
8. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates, 2nd edn. Sydney: Academic Press, 1988.
9. Handley SL and Mithani S. Naunyn-Schmiedeberg's Arch Pharmacol 327, 1-5 (1984)
10. Harro J. Measurement of exploratory behavior in rodents. In: Conn PM, ed. Paradigms for the Study of Behavior. San Diego: Academic Press, 1993: 359-377.
11. Broqua P, Wettstein JG, Rocher MN et al. Behav Pharmacol 6, 215-222 (1995).
12. Dunn AJ and Berridge CW. Pharmacol Biochem Behav 27, 685-691 (1987).
13. Lee EHY, Chang SY and Chen AYJ. Neurosci Res 19, 327-330 (1994).
14. Lavicky J and Dunn AJ. Neurochem 60, 602-612 (1993).
15. Smagin GN, Swiergiel AH and Dunn AJ. Brain Res Bull 36, 71-76 (1995).
16. Schultz C and Lehnert H, Neuroendocrinology 63, 454-458 (1996).
17. Stanford SC. Pharmacol Ther 68, 297-342 (1995).
18. Martire M, Pistritto G, Mores N et al. Eur J Pharmacol 230, 231-234 (1993).
19. Martire M, Pistritto G, Mores N et al. Neurosci Lett 188, 9-12 (1995).
20. Shibasaki T, Tsumori C, Hotta M et al. Brain Res 688, 189-192 (1995).